Understanding the inflammatory cycle is key to understanding why so many modern health concerns persist. Increasing evidence now points to molecular hydrogen as a potential tool for moderating this cycle and supporting overall cellular health.
Researchers have identified 140 genes that could change how non-small cell lung cancer (NSCLC) patients are treated with immunotherapy and low-dose radiation.
The Food and Drug Administration (FDA) has an approach for the expanded use of Omalizumab (Xolair), to address allergic reactions, including anaphylaxis, stemming from accidental exposure to various foods.
Researchers from Amsterdam UNC and Radboundumc have revealed a method to predict the effectiveness of antidepressants within a week of treatment
This advancement powered by...
Biologic therapies can effectively control severe asthma without the need for regular high-dose inhaled steroids, a significant revelation that could transform the lives of millions grappling with the condition.
